Clinical trial
Lapatinib and Whole Brain Radiotherapy for patients with brain metastases from lung and breast tumors. A phase II study of the Hellenic Cooperative Oncology Group (HeCOG).
The main objective of the study is to measure the response rate in brain as assessed by volumetric analysis of brain MRI.
| Category | Value |
|---|---|
| Study start date | 2009-10-07 |